INDICATOR NAME
Name
Antibiotic-resistant bloodstream infections
Alternate Name
Rate of antibiotic-resistant bloodstream infections per 1,000 inpatient days
INDICATOR DESCRIPTION
Description
This indicator measures the incidence rate of nosocomial (hospital-acquired) Methicillin-resistant Staphylococcus areus (MRSA) and Vancomycin-resistant Enterococcus (VRE) infections associated with the reporting facility per 1,000 inpatient days.
Indicator Status
Active
HQO Reporting tool/product
Public reporting
Dimension
Safe
Type
Outcome
DEFINITION AND SOURCE INFORMATION
Unit of Measurement
Rate per 1,000 inpatient days
Calculation Methods
Numerator divided by denominator times 1,000
Numerator including inclusion/exclusion
MRSA:
1.Laboratory-confirmed bloodstream MRSA bacteremia cases (i.e. confirmation through a single positive blood culture for MRSA);
2. New nosocomial cases associated with the reporting facility, where the infection was not present on admission (i.e. onset of symptoms >72 hours after admission) or the infection was present at the time of admission but was related to a previous admission to the same facility within the last 72
VRE:
1. Laboratory-confirmed bloodstream VRE bacteremia cases (i.e confirmation through a single positive blood culture for VRE);
2. New nosocomial cases associated with the reporting facility where the infection was not present on admission (i.e. onset of symptoms >72 hours after admission) or the infection was present at the time of admission but was related to a previous admission to the same facility within the alst 72 hours.
Inclusion:
1. All publicly funded hospitals
2. Inpatient beds
Exclusion:
1. New case associated with other health care facility.
2. New case associated with a source other than a health care facility or unknown/indeterminate source
1.Laboratory-confirmed bloodstream MRSA bacteremia cases (i.e. confirmation through a single positive blood culture for MRSA);
2. New nosocomial cases associated with the reporting facility, where the infection was not present on admission (i.e. onset of symptoms >72 hours after admission) or the infection was present at the time of admission but was related to a previous admission to the same facility within the last 72
VRE:
1. Laboratory-confirmed bloodstream VRE bacteremia cases (i.e confirmation through a single positive blood culture for VRE);
2. New nosocomial cases associated with the reporting facility where the infection was not present on admission (i.e. onset of symptoms >72 hours after admission) or the infection was present at the time of admission but was related to a previous admission to the same facility within the alst 72 hours.
Inclusion:
1. All publicly funded hospitals
2. Inpatient beds
Exclusion:
1. New case associated with other health care facility.
2. New case associated with a source other than a health care facility or unknown/indeterminate source
Denominator including inclusion/exclusion
Total number of inpatient days in the reporting period
Inclusion:1. All publicly funded hospitals;
2. Inpatient beds
Adjustment (risk, age/sex standardization)- detailed
None
Data Source
Self-Reporting Initiative (SRI)
Data provided to HQO by
Ministry of Health and Long-Term Care (MOHLTC)
Reported Levels of comparability /stratifications (defined)
Institution, Province, Time
RESULT UPDATES
Indicator Results
OTHER RELEVANT INFORMATION
Caveats and Limitations
Data are self-reported by hospitals.
TAGS
Sector
Acute Care/Hospital
Type
Outcome
Topic
Patient Safety and Never Events
Dimension
Safe
Source
Self-Reporting Initiative (SRI)
PUBLISH
Publish Datetime
19/10/2017 12:08:00
Excel 
PDF
TIFF 
Word 
XML
CSV